Loading...
Bevacizumab
India Pharmaceutical Trade Intelligence
Who Supplies Bevacizumab to India from GERMANY
India's bevacizumab imports from GERMANY total $344.1M across 54 shipments from 12 foreign suppliers. F. HOFFMANN -LA ROCHE LTD leads with $323.9M in import value; the top 5 suppliers together control 99.6% of this origin. Leading Indian buyers include ROCHE PRODUCTS (INDIA) PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for bevacizumab — a diversified sourcing base with multiple active suppliers from GERMANY.
Top foreign suppliers (GERMANY) — Ranked by import value
F. HOFFMANN -LA ROCHE LTD is the leading Bevacizumab supplier from GERMANY to India, with import value of $323.9M across 3 shipments. The top 5 suppliers — F. HOFFMANN -LA ROCHE LTD, F. HOFFMANN -LA ROCHE LTD.,, CELTIS HEALTHCARE LLC, FISHER CLINICAL SERVICES GMBH, F HOFFMANN-LA ROCHE LIMITED — collectively account for 99.6% of total import value from this origin.
Top foreign suppliers (GERMANY)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | F. HOFFMANN -LA ROCHE LTD | $323.9M | 3 | 94.1% |
| 2 | F. HOFFMANN -LA ROCHE LTD., | $15.9M | 26 | 4.6% |
| 3 | CELTIS HEALTHCARE LLC | $2.0M | 3 | 0.6% |
| 4 | FISHER CLINICAL SERVICES GMBH | $522.7K | 1 | 0.2% |
| 5 | F HOFFMANN-LA ROCHE LIMITED | $439.3K | 3 | 0.1% |
| 6 | F HOFFMANN-LA ROCHE LTD | $393.2K | 4 | 0.1% |
| 7 | F. HOFFMANN-LA ROCHE LTD. | $356.6K | 4 | 0.1% |
| 8 | F HOFFMANN LA ROCHE LTD | $294.2K | 2 | 0.1% |
| 9 | F. HOFFMANN -LA ROCHE LIMITED | $199.4K | 3 | 0.1% |
| 10 | F.HOFFMANN -LA ROCHE LTD | $73.6K | 1 | 0.0% |
| 11 | BIO-RAD ABD SEROTEC LTD, | $10.8K | 3 | 0.0% |
| 12 | NEWLIFE BIOPHARMA LIMITED | $592 | 1 | 0.0% |
Showing top 12 of 12 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from GERMANY)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ROCHE PRODUCTS (INDIA) PRIVATE LIMITED | $340.4M | 37 | 98.9% |
| 2 | CURATEQ BIOLOGICS PRIVATE LIMITED | $2.6M | 4 | 0.7% |
| 3 | ROCHE PRODUCTS I PRIVATE LIMITED | $439.3K | 3 | 0.1% |
| 4 | ROCHE PRODUCTS I PVT LTD | $393.2K | 4 | 0.1% |
| 5 | ROCHE PRODUCTS INDIA PRIVATE LIMITED | $294.2K | 2 | 0.1% |
| 6 | BIO-RAD LABORATORIES (INDIA) PRIVATE LIMITED | $10.8K | 3 | 0.0% |
| 7 | ZYDUS LIFESCIENCES LIMITED | $592 | 1 | 0.0% |
Import Statistics
- Import Value
- $344.1M
- Shipments
- 54
- Foreign Suppliers
- 12
- Indian Buyers
- 7
- Avg. Shipment
- $6.4M
Other Bevacizumab Import Origins
Related Analysis
Frequently Asked Questions — Bevacizumab Imports from GERMANY
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Bevacizumab suppliers from GERMANY to India?
The top Bevacizumab suppliers from GERMANY to India include F. HOFFMANN -LA ROCHE LTD, F. HOFFMANN -LA ROCHE LTD.,, CELTIS HEALTHCARE LLC. The leading supplier is F. HOFFMANN -LA ROCHE LTD with import value of $323.9M USD across 3 shipments. India imported Bevacizumab worth $344.1M USD from GERMANY in total across 54 shipments.
QHow much Bevacizumab does India import from GERMANY?
India imported Bevacizumab worth $344.1M USD from GERMANY across 54 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Bevacizumab from GERMANY?
The main Indian buyers of Bevacizumab sourced from GERMANY include ROCHE PRODUCTS (INDIA) PRIVATE LIMITED, CURATEQ BIOLOGICS PRIVATE LIMITED, ROCHE PRODUCTS I PRIVATE LIMITED. The largest buyer is ROCHE PRODUCTS (INDIA) PRIVATE LIMITED with $340.4M in imports across 37 shipments.
QWhat is the total value of Bevacizumab imports from GERMANY to India?
The total value of Bevacizumab imports from GERMANY to India is $344.1M USD, across 54 shipments and 12 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: GERMANY to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Bevacizumab.
- 2.Supplier/Buyer Matching: 12 foreign suppliers from GERMANY and 7 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $344.1M aggregated from 54 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
54 Verified Shipments
12 suppliers, 7 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists